Lipid Efficacy/Tolerability Study (0524A-020)

Clinical trial NCT00269204 · COMPLETED

Trial details

NCT number: NCT00269204
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Hypercholesterolaemia Mixed Hyperlipidaemia

Start date: 2005-12-01
Primary completion: 2006-12-01
Enrollment: 1620

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.